9.16
Avantor Inc stock is traded at $9.16, with a volume of 9.53M.
It is down -3.78% in the last 24 hours and up +13.79% over the past month.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
See More
Previous Close:
$9.52
Open:
$9.53
24h Volume:
9.53M
Relative Volume:
0.98
Market Cap:
$6.25B
Revenue:
$6.55B
Net Income/Loss:
$-551.40M
P/E Ratio:
-11.33
EPS:
-0.8082
Net Cash Flow:
$438.90M
1W Performance:
+0.44%
1M Performance:
+13.79%
6M Performance:
-16.19%
1Y Performance:
-29.27%
Avantor Inc Stock (AVTR) Company Profile
Name
Avantor Inc
Sector
Industry
Phone
(610) 386-1700
Address
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
AVTR
Avantor Inc
|
9.16 | 6.50B | 6.55B | -551.40M | 438.90M | -0.8082 |
|
ISRG
Intuitive Surgical Inc
|
422.06 | 148.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
151.16 | 41.21B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
66.81 | 32.47B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
196.04 | 28.19B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
33.61 | 29.13B | 29.14B | 1.07B | 1.05B | 1.1956 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-05-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-17-25 | Downgrade | Jefferies | Hold → Underperform |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-04-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-30-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-01-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-29-25 | Downgrade | Goldman | Buy → Neutral |
| Apr-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Apr-28-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-17-25 | Downgrade | UBS | Buy → Neutral |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Downgrade | Citigroup | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-11-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-31-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-21-23 | Initiated | RBC Capital Mkts | Outperform |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Oct-05-22 | Upgrade | Citigroup | Neutral → Buy |
| Sep-14-22 | Downgrade | Cowen | Outperform → Market Perform |
| Sep-09-22 | Downgrade | Cleveland Research | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-30-21 | Resumed | Raymond James | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Aug-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-04-21 | Initiated | Goldman | Buy |
| Apr-29-21 | Upgrade | Stifel | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Aug-02-19 | Initiated | Cleveland Research | Neutral |
| Jun-14-19 | Initiated | Janney | Buy |
| Jun-12-19 | Initiated | Raymond James | Outperform |
| Jun-11-19 | Initiated | Goldman | Buy |
| Jun-11-19 | Initiated | Guggenheim | Buy |
| Jun-11-19 | Initiated | JP Morgan | Overweight |
| Jun-11-19 | Initiated | Jefferies | Buy |
| Jun-11-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| Jun-11-19 | Initiated | RBC Capital Mkts | Outperform |
| Jun-11-19 | Initiated | Robert W. Baird | Outperform |
| Jun-11-19 | Initiated | SunTrust | Buy |
| Jun-11-19 | Initiated | UBS | Buy |
| Jun-11-19 | Initiated | William Blair | Outperform |
View All
Avantor Inc Stock (AVTR) Latest News
Avantor, Inc. Trade Ideas — XETR:AVG - TradingView
Price to sales ratio of Avantor, Inc. – XETR:AVG - TradingView
Avantor, Inc. Cash Flow – XETR:AVG - TradingView
Avantor, Inc. Balance Sheet – XETR:AVG - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR - The National Law Review
2026-06-04 | Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Shareholders to Inquire about Securities Investigation | NYSE:AVTR | Press Release - Stockhouse
Here's why you should hold Avantor stock in your portfolio for now - MSN
Responsive Playbooks and the AVTR Inflection - Stock Traders Daily
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Wolfe Research initiates Avantor stock with underperform rating By Investing.com - Investing.com South Africa
Wolfe Research initiates Avantor stock with underperform rating - Investing.com
Wolfe Research Initiates Avantor(AVTR.US) With Sell Rating, Announces Target Price $7 - Moomoo
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Investors to Connect - ACCESS Newswire
Is Avantor (AVTR) Elevating Quality To A Strategic Edge With Its New Regulatory Chief? - Yahoo Finance
Avantor (AVTR) Appoints Ludovic Brellier as EVP and Chief Transformation Officer - Insider Monkey
Avantor, Inc. (AVTR) Stock Analysis: Evaluating the 8% Potential Upside Amidst Mixed Performance Metrics - DirectorsTalk Interviews
Avantor, Inc. Hits Day High with Strong 8.93% Intraday Surge - Markets Mojo
Zuckerman Investment Group, LLC's Avantor Inc(AVTR) Holding History - GuruFocus
Why Is Avantor (AVTR) Up 13% Since Last Earnings Report? - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now - Yahoo Finance
Avantor Inc stock (US0543031027): shares trade lower after recent slide despite solid Q1 update - AD HOC NEWS
RBC Capital Initiates Avantor (AVTR) With Sector Perform Rating - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Insider Stock Buying Reaches US$9.94m On Avantor - 富途牛牛
Smart Money Is Buying Avantor Inc. (AVTR) - The Acquirer's Multiple
Avantor, Inc. (AVTR) Stock Analysis: Navigating Potential 21.39% Upside in the Healthcare Sector - DirectorsTalk Interviews
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Radnor-based Avantor opens St. Louis facility - Pennsylvania Business Report -
Understanding the Setup: (AVTR) and Scalable Risk - Stock Traders Daily
Avantor (AVTR): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Circumference Group LLC's Avantor Inc(AVTR) Holding History - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Avantor’s SWOT analysis: life sciences stock faces mounting pressures By Investing.com - Investing.com Nigeria
Avantor appoints Gerard Porreca as quality and regulatory EVP - Investing.com UK
Avantor® Announces Gerard (Jerry) Porreca as Executive Vice Pres - GuruFocus
Avantor appoints Gerard Porreca as quality and regulatory EVP By Investing.com - Investing.com South Africa
Global Cell Culture Media Market Outlook 2026-2036: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG - PR Newswire UK
Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory - Financial Times
Avantor’s SWOT analysis: life sciences stock faces mounting pressures - Investing.com
Avantor (AVTR) Fell as Destocking Has Lasted Longer Than Expected - Insider Monkey
Avantor (AVTR) Slid on Lower Than Expected Guidance - Insider Monkey
Avantor stock (US0543031027): focus shifts to margin recovery after Q1 earnings - AD HOC NEWS
Avantor, Inc. Common Stock (NY: AVTR - The Chronicle-Journal
Avantor's Turnaround Story Ongoing, Execution Risks Remain, RBC Says - marketscreener.com
Avantor Inc Stock (AVTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):